Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bonny Parkinson

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Australian Health Review : a Publication of the Australian Hospital Association|December 14, 2021
Application of an economic evaluation approach to making regulatory decisions regarding access to medicines: advantages, challenges and recommendationsBonny Parkinson, Henry Cutler
Health Policy (Amsterdam, Netherlands)|October 22, 2010
Considering consumer choice in the economic evaluation of mandatory health programmes: a reviewBonny Parkinson, Stephen Goodall
Applied Health Economics and Health Policy|March 16, 2013
Measuring the loss of consumer choice in mandatory health programmes using discrete choice experimentsBonny Parkinson, Stephen Goodall, Richard Norman
The Journal of Nutrition|December 11, 2012
The cost-effectiveness of mandatory folic acid fortification in AustraliaViktoria Rabovskaja, Bonny Parkinson, Stephen Goodall
ANZ Journal of Surgery|November 30, 2012
Cost-effectiveness of lumbar artificial intervertebral disc replacement: driven by the choice of comparatorBonny Parkinson, Stephen Goodall, Prema Thavaneswaran
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 26, 2013
Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critiqueBonny Parkinson, Sallie-Anne Pearson, Rosalie Viney
Health Policy (Amsterdam, Netherlands)|March 22, 2026
Accessing the risks: A mixed methods study of risk management in Australian pharmaceutical market accessZachary Tirrell, Sean Lybrand, Neil Soderlund, et al.
Value in Health Regional Issues|April 2, 2018
Cost Effectiveness of a Community-Delivered Consultation to Improve Infant Sleep Problems and Maternal Well-BeingSopany Saing, Bonny Parkinson, Jody Church, et al.
Pharmacoeconomics|May 10, 2019
Is Reclassification of the Oral Contraceptive Pill from Prescription to Pharmacist-Only Cost Effective? Application of an Economic Evaluation Approach to Regulatory DecisionsMutsa Gumbie, Bonny Parkinson, Henry Cutler, et al.
Pharmacoeconomics|June 27, 2022
Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in AustraliaRachel Song, Varinder Jeet, Rajan Sharma, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Australian Health Review : a Publication of the Australian Hospital Association|December 14, 2021
Application of an economic evaluation approach to making regulatory decisions regarding access to medicines: advantages, challenges and recommendationsBonny Parkinson, Henry Cutler
Health Policy (Amsterdam, Netherlands)|October 22, 2010
Considering consumer choice in the economic evaluation of mandatory health programmes: a reviewBonny Parkinson, Stephen Goodall
Applied Health Economics and Health Policy|March 16, 2013
Measuring the loss of consumer choice in mandatory health programmes using discrete choice experimentsBonny Parkinson, Stephen Goodall, Richard Norman
The Journal of Nutrition|December 11, 2012
The cost-effectiveness of mandatory folic acid fortification in AustraliaViktoria Rabovskaja, Bonny Parkinson, Stephen Goodall
ANZ Journal of Surgery|November 30, 2012
Cost-effectiveness of lumbar artificial intervertebral disc replacement: driven by the choice of comparatorBonny Parkinson, Stephen Goodall, Prema Thavaneswaran
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 26, 2013
Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critiqueBonny Parkinson, Sallie-Anne Pearson, Rosalie Viney
Health Policy (Amsterdam, Netherlands)|March 22, 2026
Accessing the risks: A mixed methods study of risk management in Australian pharmaceutical market accessZachary Tirrell, Sean Lybrand, Neil Soderlund, et al.
Value in Health Regional Issues|April 2, 2018
Cost Effectiveness of a Community-Delivered Consultation to Improve Infant Sleep Problems and Maternal Well-BeingSopany Saing, Bonny Parkinson, Jody Church, et al.
Pharmacoeconomics|May 10, 2019
Is Reclassification of the Oral Contraceptive Pill from Prescription to Pharmacist-Only Cost Effective? Application of an Economic Evaluation Approach to Regulatory DecisionsMutsa Gumbie, Bonny Parkinson, Henry Cutler, et al.
Pharmacoeconomics|June 27, 2022
Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in AustraliaRachel Song, Varinder Jeet, Rajan Sharma, et al.
Pageof 6